Metastatic Hepatocellular Carcinoma
Also known as: Hepatocellular Carcinoma Metastatic / Metastatic hepatocellular carcinoma (morphologic abnormality) / Hepatocellular carcinoma / Carcinoma hepatocellular / Hepatoma / Primary carcinoma of liver (disorder) / Liver carcinoma / (Liver carcinoma) or (Ca: [liver/biliary system] or [biliary system]) / Carcinoma liver / Liver cell carcinoma (disorder) / Hepatocellular carcinoma (morphologic abnormality) / Carcinoma of liver / Carcinoma, Hepatocellular
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11595 | Atezolizumab | A monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy. |
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |